News Samsung Bioepis and Takeda begin first trial from R&D tie-up Companies signed risk-sharing deal last year
AbbVie Biogen gets go-ahead for EU Humira launch in October But deal with Samsung prevents US launch until mid-2023
News Samsung Bioepis Herceptin biosimilar approved in EU Mylan and Biocon resolve biosimilar manufacturing issues
News Ready to pounce: Samsung joins Amgen with Humira biosimilar ... No-one can launch biosimilars until patent expires next year
News Samsung Bioepis signs R&D agreement with Takeda South Korean firm looking to develop novel drugs
News Regulators finally back Merck KGaA oral MS drug A long-awaited oral multiple sclerosis drug from Merck KGaA was among a raft of medicines given the green light by Europe's regulator on Friday.
